The Department of Pharmaceutics of Institute of Medicinal of Biotechnology was founded in June 2002. The first director was Professor LI Mei and the present director is Professor WANG Yucheng.

The department specializes in the science and technology associated with innovations in drug delivery and drug development. The major areas of research in this department focus on anti-tumor drug delivery system, anti-infection drug delivery system, controlled-release drug delivery system, targeting drug delivery system, nanopartical drug delivery system and environment-responsive drug delivery system. The department has successively participated in several projects supported by the government including National Natural Science Foundation of China and Science-Technology Project of the National " Eleventh/Twelfth/Thirteenth Five-Year-Plans" of China and the National Key Research and Development Program of China，etc. In past several years, more than 20 SCI papers were published in the domestic and international journals in this department. In addition, more than 20 patents were applied and authorized.

The department has well-equipped key instruments for general solid and liquid formulations, self-emulsifying and self- microemulsifying nano-formulations, nano-micelle formulations, lipidosome formulations and in situ gels formulations, etc.. The Department is also equipped with advanced instruments for analytical and pharmaceutical process research, including MicroCal Isothermal Titration Calorimeter High Pressure Homogenizer, Laser Nanometer Particle Size Analyzer, High Performance Liquid Chromatograph, Gas Chromatograph, Simultaneous Thermal Analyzer, Vacuum Freeze Drier, Rotational Rheometer, Texture Analyser, Dissolution Tester, Automatic Rotary Pelleting Machine, High-efficent Coating Machine, Powder Characteristics Tester, etc.. The department has high level of experiences in screening novel drug candidates, optimization of preparation technique, establishing drug quality standards, development of drug formulation and procedure of drug registration. To date, more than 40 pharmaceutical preparations have been applied and registered. The long-term relationships in drug development and technical cooperation were established with numbers of domestic pharmaceuticals companies. An efficient platform for the development of drug delivery technology and novel drug formulations has been established. In the future, the department plan to make great efforts in the innovations in drug delivery and drug development.

Research groups: XIA Guimin's group and LI Guiling's group.